Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

eClinical Solution Companies

The eClinical solutions market had been experiencing significant growth, with several companies providing technology and services to streamline and enhance clinical trial processes. While there may have been new developments in the industry since then, here are some companies known for their involvement in providing eClinical solutions.

eClinical Solution Key Companies*Disclaimer: List of key companies in no particular orderLatest eClinical solutions Companies Update



  • Aug 2023: Partex, the first Data-to-Drugs pharma platform, and Parexel, one of the largest clinical research organizations (CROs) in the world that offers an array of Phase I to IV clinical development services, today announced a preferred strategic alliance to use artificial intelligence (AI)-powered remedies to quicken drug discovery and development for biopharmaceutical customers globally and de-risk the assets in their portfolios. The combined goals of Parexel and Partex are to enhance patient outcomes and foster a culture of ongoing innovation through cutting-edge technology, data-driven insights, and collaborative ecosystems. Drug builders' efforts to understand the likelihood of clinical success of assets within their portfolio and endorse other disease indications for which their products may be clinically viable are expected to be further advanced by Parexel's extensive global expertise throughout Phase I to IV clinical development. This expertise will be complemented by Partex's big data and AI capabilities.




  • Sep 2023: Oracle Corp. and Microsoft Corp. unveiled Oracle Database@Azure, a service that allows users direct access to Oracle database services installed in Microsoft Azure datacenters and run on Oracle Cloud Infrastructure (OCI). Oracle Database@Azure combines the security, adaptability, and best-in-class services of Microsoft Azure with all the achievement, scale, and workload availability benefits of Oracle Database on OCI. This includes best-in-class AI capabilities like Azure OpenAI. Thanks to this combination, customers now have greater options in operating their workloads. Additionally, it offers a streamlined environment that makes using Oracle Database and Azure services for cloud purchasing and management easier. Oracle and Microsoft are assisting clients in hastening their migration to the cloud by releasing Oracle Database@Azure, allowing them to modernize their IT environments and benefit from Azure's architecture.List of eClinical solutions Key companies in the market


• ERT Clinical

• PAREXEL International Corporation


• BioClinica Inc.


• CRF Health


• Oracle Corporation


• DATATRAK International Inc.


• Merge Healthcare Inc


• Medidata Solutions Inc.


• Omnicomm Systems


• MaxisIT

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.